European principles of inhibitor management in patients with haemophilia: implications of new treatment options

Orphanet J Rare Dis. 2020 Aug 24;15(1):219. doi: 10.1186/s13023-020-01511-8.
No abstract available

Keywords: Bypassing agents; Emicizumab; Factor IX; Factor VIII; Guidelines; Haemophilia; Immune tolerance; Inhibitors.

Publication types

  • Letter

MeSH terms

  • Factor IX
  • Factor VIII
  • Hemophilia A* / drug therapy
  • Humans
  • Medicine*
  • Sex Chromosome Disorders*

Substances

  • Factor VIII
  • Factor IX